Placemark Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Placemark Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$539K	Sell	8,676 -6,297	-42%	-$359K	0.01%	1142
2014 Q3	$779K	Sell	14,973 -1,824	-11%	-$93K	0.01%	986
2014 Q2	$861K	Buy	+16,797	New	+$757K	0.02%	936
2014 Q1	–	Sell	-7,962	Closed	-$345K	–	1674
2013 Q4	$345K	Buy	+7,962	New	+$330K	0.01%	1285

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Placemark Investments's XBI Position: Q4 2014 in Review

Placemark Investments reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 42% in Q4 2014, selling an estimated $359K and leaving 8,676 shares worth $539K. The position accounts for 0.01% of the portfolio, ranked #1142.

Placemark Investments first reported a position in XBI in Q4 2013 and has held it in 4 quarters since. The position peaked at $861K in Q2 2014. 146 funds tracked by Wall St. Rank hold XBI as of Q4 2014.

Placemark Investments held 8,676 shares of State Street SPDR S&P Biotech ETF worth $539K as of Q4 2014.
Placemark Investments sold 6,297 State Street SPDR S&P Biotech ETF shares in Q4 2014, an estimated $359K.
State Street SPDR S&P Biotech ETF made up 0.01% of Placemark Investments's portfolio in Q4 2014, its #1142 holding.
Placemark Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2013 and has held it in 4 quarters since.
Placemark Investments's State Street SPDR S&P Biotech ETF position peaked at $861K in Q2 2014.
146 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.